🔗 Share this article

An underground market for unlicensed weight-loss medications is propelled by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.

Experimental Treatment Gaining Traction Via Social Media

Retatrutide, which is still in research studies, is being promoted by social media influencers for its alleged fat-burning effects. Followers are urged to contact these profiles directly for source information, while also receiving discount codes.

Thriving Commerce on Messaging Platforms

Separately, a flourishing market exists on messaging services, where groups with thousands of participants share “before and after” images, administration instructions and assertions of rapid British shipping. Vendors promote the substance there before directing customers to other platforms for purchases.

Understanding The Experimental Drug

This medication is an investigational injection developed by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials suggest it could assist patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed digitally as the next Ozempic.

Medical Professionals Express Concerns

However, doctors and chemists have cautions that the sale of what remains an unapproved medication in the UK is worrisome and could lead to users injecting substances of uncertain source.

Some experts said the popularity for retatrutide could be linked to the rising cost of approved weight loss products such as Mounjaro.

Legal Position and Enforcement

Marketing retatrutide on social media or Telegram is illegal in the United Kingdom, as it is an unlicensed medication that must not be promoted or distributed for human use under the Human Medicines Regulations 2012.

Some content creators try to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and distribution can still breach pharmaceutical, advertising, and consumer laws, risking penalties, legal action or prison.

Platform Reaction and Material Elimination

According to the social media company, the service has removed problematic content and banned associated keywords and query recommendations. The company said it was committed to maintaining the service safe and allocating resources in strengthening compliance measures.

Online Trading Activities

Investigations also discovered groups with up to 9,000 members selling retatrutide using the platform's built-in discovery tool, which functions like a public directory. Typing “retatrutide” instantly brings up groups with thousands of users, filled with images of slimming results, positive testimonials and step-by-step guides for preparing or injecting at residence.

After moments of entering one group, a seller shared WhatsApp details, where the majority of purchases occur. The seller sent an instruction manual and guaranteed shipping within two days. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one inquired about weight, health issues or past usage.

Item Details and Costs

Within these communities, posts show black plastic parcels with Royal Mail labels, claiming to include fresh supplies. One communication read: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at residence with purified liquid, or ready-to-use pens typically priced at 160 pounds for 20 milligrams. When asked how much time a pen should be used, sellers give contradictory answers varying between a few weeks to “depends on your body”.

Service Moderation and Security Measures

A spokesperson for Telegram said it regularly monitored harmful material on its platform including content that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are administering substances they cannot confirm. Although the research behind retatrutide is valid, these digital products may not include what they claim,” stated Jason Murphy, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service connected the surge in demand to recent price rises for approved weight-loss drugs such as Mounjaro. “With costs rising, individuals are turning to online platforms. But counterfeit injections are highly dangerous. You can’t be certain what’s contained or whether the environment they were made in was clean,” she explained.

Her staff has already encountered individuals harmed by personal administration from unconfirmed suppliers. “We recognize the frustration, but purchasing from Telegram or communication platforms is taking chances with your well-being,” stated Wyllie. “These substances could be contaminated or incorrectly dosed.”

Manufacturer Position

A spokesperson from Eli Lilly stated retatrutide was in phase 3 clinical trials and had not been reviewed or authorized by any government authority globally. “Therefore at this point no one can sell [it] for personal consumption,” they said, noting that any item “misleadingly claiming itself as a Lilly experimental product not yet authorized … may expose users to potentially significant medical dangers”.